Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A2N8PC / Name: Agex Therapeutics Inc. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Agex Therapeutics Inc. Stock

Pros and Cons of Agex Therapeutics Inc. in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

AgeX Therapeutics Reports Third Quarter 2023 Financial Results: https://mms.businesswire.com/media/20191108005662/en/711989/5/AGEX_High_Resolution_300dpi.jpg
AgeX Therapeutics Reports Third Quarter 2023 Financial Results


AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter